Furthermore, MFs with a more pro-inflammatory CCR2+ phenotype are rather localized perivascularly and in the peritumoral stroma, contributing to neoangiogenesis and the pro-inflammatory tumor microenvironment, while M2-like CCR2− TAMs are rather located in hypoxic areas and cancer nests [110,361,374]. Here, CCR2 is linked to cancer.